Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

This intervention will focus on stimulant-using men at high risk for HIV who are in need of tailored behavioral interventions to mitigate co-occurring stimulant use and HIV risk in the era of pre-exposure prophylaxis (PrEP). The study is a pilot randomized controlled trial to evaluate the adaptation, feasibility, acceptability, and preliminary efficacy of a behavioral intervention.

Inclusion Criteria:

1. be 18 years of age or older;
2. be sexually active cisgender men at high risk for HIV (foreign and US-born, residing in the US)-reporting any condomless anal sex (CAS) in the past three months with a man;
3. report use of stimulant (i.e., methamphetamine, powder cocaine, or crack-cocaine) at least one day in the past three or six month;
4. have HIV-negative serostatus;
5. be bilingual (Spanish and English), or Spanish or English monolingual;
6. meet CDC criteria for PrEP eligibility.

Exclusion Criteria:

1. display diminished capacity to consent (e.g., cognitive impairment); or
2. severe psychiatric symptoms (e.g., psychosis) that require more intensive treatment;
3. if they are HIV positive or living with HIV;
4. if they are already taking PrEP; and
5. if the participant can't consent to participate in English or Spanish.